Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10277-1 | Temsirolimus | LSM-4295 |  | 148191 | |
| 10278-1 | Topotecan | Hycamtin | LSM-5662 |  | 60700 |
| 10279-1 | Trichostatin A | LSM-43005 |  | ||
| 10280-1 | Triciribine | LSM-3810 |  | 65399 | |
| 10281-1 | Vinorelbine | Navelbine | LSM-6302 |  | 5311497 |
| 10282-1 | Vorinostat | suberoylanilide hydroxamic acid (SAHA); Zolinza | LSM-3828 |  | 5311 |
| 10283-1 | XRP44X | AG-G-87906 | LSM-4298 |  | 10339779 |
| 10343-1 | Baicalein | LSM-6355 |  | 5281605 | |
| 10344-1 | Olomoucine II | LSM-6356 |  | 10067756 | |
| 10345-3 | Torkinib | PP242 | LSM-6357 |  | 57347681 |
| 10346-1 | Valproic acid | Depakine | LSM-4620 |  | 3549980 |
| 10348-1 | Z-Leu-Leu-Norvalinal | MG-115 | LSM-6358 |  | 9868928 |
| 10501-1 | 2-deoxyglucose | 2-deoxy-D-glucose; 2-Desoxy-D-glucose; 2-DG |  | 9062 | |
| 10502-1 | Bromopyruvic acid | 3-bromopyruvic acid; Bromopyruvate |  | 70684 | |
| 10503-1 | Celecoxib | Celebrex; Celebra; Celecox; Onsenal; Solexa; SC-58635; YM-177 |  | 2662 | |
| 10504-1 | Chk2 inhibitor II | BML-277 |  | 9969021 | |
| 10505-1 | Chloroquine |  | 2719 | ||
| 10506-1 | Dichloroacetate |  | 25975 | ||
| 10507-1 | Disulfiram | Tetraethylthiuram disulfide; TETD |  | 3117 | |
| 10508-1 | FTase Inhibitor I | B581 |  | 132887 | |
| 10509-1 | GM6001 | Ilomastat; Galardin; GM-6001 |  | 132519 | |
| 10510-1 | LY294002 | LY-294002 |  | 3973 | |
| 10511-1 | Mebendazole | Vermox |  | 4030 | |
| 10512-1 | Methylglyoxal | Acetylformaldehyde; Pyruvaldehyde |  | 880 | |
| 10513-1 | Nelfinavir | Viracept |  | 64143 |